{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T10:47:47Z","timestamp":1792406867675,"version":"4.4.0"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"DOI":"10.3389\/fchem.2018.00360","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:35:50Z","timestamp":1534725350000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":723,"title":["Nanomedicine: Principles, Properties, and Regulatory Issues"],"prefix":"10.3389","volume":"6","author":[{"given":"Sara","family":"Soares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Vitorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/21691401.2016.1178134","article-title":"Biocompatibility and nanostructured materials: applications in nanomedicine","volume":"45","author":"Adabi","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2217\/nnm-2017-0039","article-title":"Challenges associated and approaches for successful translation of nanomedicines into commercial products","volume":"12","author":"Agrahari","year":"2017","journal-title":"Nanomedicine"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-bioeng-071811-150124","article-title":"The effect of nanoparticle size, shape, and surface chemistry on biological systems","volume":"14","author":"Albanese","year":"2012","journal-title":"Annu. Rev. Biomed. Eng"},{"key":"B4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.taap.2011.11.010","article-title":"Nanotoxicology and in vitro studies: the need of the hour","volume":"258","author":"Arora","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.yrtph.2014.07.025","article-title":"A critical appraisal of existing concepts for the grouping of nanomaterials","volume":"70","author":"Arts","year":"2014","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.yrtph.2015.11.020","article-title":"Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice","volume":"76","author":"Arts","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/nyas.13382","article-title":"How to select a nanosimilar","volume":"1407","author":"Astier","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.2217\/nnm.15.130","article-title":"Nanotoxicology: advances and pitfalls in research methodology","volume":"10","author":"Azhdarzadeh","year":"2015","journal-title":"Nanomedicine"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.nano.2017.05.014","article-title":"Quality-by-design of nanopharmaceuticals\u2013a state of the art","volume":"13","author":"Bastogne","year":"2017","journal-title":"Nanomedicine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.yrtph.2012.11.007","article-title":"Considerations on the EU definition of a nanomaterial: science to support policy making","volume":"65","author":"Bleeker","year":"2013","journal-title":"Regul. Toxicol. Pharmacol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.yrtph.2015.06.001","article-title":"Comparative assessment of nanomaterial definitions and safety evaluation considerations","volume":"73","author":"Boverhof","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.yrtph.2006.04.009","article-title":"Nanomedicine: an unresolved regulatory issue","volume":"46","author":"Chan","year":"2006","journal-title":"Regul. Toxicol. Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40005-017-0370-4","article-title":"Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics","volume":"48","author":"Choi","year":"2018","journal-title":"J. Pharm. Investig."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1413","DOI":"10.1002\/wnan.1413","article-title":"High throughput toxicity screening and intracellular detection of nanomaterials","volume":"9","author":"Collins","year":"2017","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"B15","first-page":"38","article-title":"Commission Recommendation of 18 October 2011 on the definition of nanomaterial 2011\/696\/EU","volume":"275","year":"2011","journal-title":"Off. J. Eur. Union L."},{"key":"B16","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fchem.2015.00048","article-title":"Nanomaterials in consumer products: a challenging analytical problem","volume":"3","author":"Contado","year":"2015","journal-title":"Front. Chem"},{"key":"B17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.taap.2015.12.014","article-title":"Emerging systems biology approaches in nanotoxicology: towards a mechanism-based understanding of nanomaterial hazard and risk","volume":"299","author":"Costa","year":"2016","journal-title":"Toxicol. Appl. Pharmacol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1016\/j.biomaterials.2007.12.037","article-title":"Particle size-dependent organ distribution of gold nanoparticles after intravenous administration","volume":"29","author":"De Jong","year":"2008","journal-title":"Biomaterials"},{"key":"B19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1208\/s12248-012-9339","article-title":"Challenges in development of nanoparticle-based therapeutics","volume":"14","author":"Desai","year":"2012","journal-title":"AAPS J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1136\/oem.2004.013243","article-title":"Nanotoxicology","volume":"61","author":"Donaldson","year":"2004","journal-title":"Occup. Environ. Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2217\/nnm.13.68","article-title":"Next-generation nanomedicines and nanosimilars: EU regulators' initiatives relating to the development and evaluation of nanomedicines","volume":"8","author":"Ehmann","year":"2013","journal-title":"Nanomedicine"},{"key":"B22","unstructured":"Reflection Paper on Non-clinical Studies for Generic Nanoparticle Iron Medicinal Product Applications2011"},{"key":"B23","unstructured":""},{"key":"B24","unstructured":"Reflection Paper on Surface Coatings: General Issues for Consideration Regarding Parenteral Administration of Coated Nanomedicine Products"},{"key":"B25","unstructured":"Reflection Paper on the Data Requirements for Intravenous Liposomal Products Developed With Reference to an Innovator Liposomal Product"},{"key":"B26","unstructured":"ICG Guideline Q8 (R2) on Pharmaceutical Development2017"},{"key":"B27","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/joim.12137","article-title":"Nanosafety: towards safer design of nanomedicines","volume":"274","author":"Fadeel","year":"2013","journal-title":"J. Intern. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2013.09.010","article-title":"Nanotoxicology","volume":"313","author":"Fadeel","year":"","journal-title":"Toxicology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/wnan.1206","article-title":"Bridge over troubled waters: understanding the synthetic and biological identities of engineered nanomaterials","volume":"5","author":"Fadeel","year":"","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.bbrc.2015.06.178","article-title":"Keeping it real: the importance of material characterization in nanotoxicology","volume":"468","author":"Fadeel","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B31","unstructured":"Guidance for Industry PAT\u2014A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. U.S Food and Drug Administration2004"},{"key":"B32","unstructured":"Guidance for Industry Considering Whether an FDA-Regulated Product Involves the Application of Nanotechnology. Food and Drug Administration2014"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17435390.2017.1415388","article-title":"Decision tree models to classify nanomaterials according to the DF4nanoGrouping scheme","volume":"12","author":"Gajewicz","year":"2018","journal-title":"Nanotoxicology"},{"key":"B34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4337\/9781849808125.00023","article-title":"Therapeutic products: regulating drugs and medical devices","volume-title":"International Handbook on Regulating Nanotechnologies","author":"Gaspar","year":"2010"},{"key":"B35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/978-3-319-08084-0_15","article-title":"Regulatory aspects of oncologicals: nanosystems main challenges","volume-title":"Nano-Oncologicals","author":"Gaspar","year":"2014"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2147\/IJN.S55359","article-title":"Nanotherapeutics in the EU: an overview on current state and future directions","volume":"9","author":"Hafner","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"B37","author":"Hodoroaba","year":"2015","journal-title":"Techniques Evaluation Report for Selection of Characterisation Methods"},{"key":"B38","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/nyas.13347","article-title":"Equivalence of complex drug products: advances in and challenges for current regulatory frameworks","volume":"1407","author":"Hussaarts","year":"2017","journal-title":"Ann. N. Y. Acad. Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/toxsci\/kfv106","article-title":"At the crossroads of nanotoxicology in vitro: past achievements and current challenges","volume":"147","author":"Hussain","year":"2015","journal-title":"Toxicol. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3109\/17435390.2013.826743","article-title":"Biological impact assessment of nanomaterial used in nanomedicine. Introduction to the NanoTEST project","volume":"9","author":"Juillerat-Jeanneret","year":"2015","journal-title":"Nanotoxicology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jconrel.2014.06.005","article-title":"Issues and concerns in nanotech product development and its commercialization","volume":"193","author":"Kaur","year":"2014","journal-title":"J. Control. Release"},{"key":"B42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/pharmaceutics5010036","article-title":"Protein adsorption patterns and analysis on IV nanoemulsions\u2014the key factor determining the organ distribution","volume":"5","author":"Keck","year":"2013","journal-title":"Pharmaceutics"},{"key":"B43","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ejpb.2013.01.001","article-title":"Nanotoxicological classification system (NCS)\u2013a guide for the risk-benefit assessment of nanoparticulate drug delivery systems","volume":"84","author":"Keck","year":"2013","journal-title":"Eur. J. Pharm. Biopharm"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1056\/NEJMra0912273","article-title":"Nanomedicine","volume":"363","author":"Kim","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.ejpb.2008.08.009","article-title":"Current in vitro methods in nanoparticle risk assessment: limitations and challenges","volume":"72","author":"Kroll","year":"2009","journal-title":"Eur. J. Pharm. Biopharm"},{"key":"B46","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11051-017-3850-6","article-title":"Safety assessment of nanomaterials using an advanced decision-making framework, the DF4nanoGrouping","volume":"19","author":"Landsiedel","year":"2017","journal-title":"J. Nanopart. Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.biotechadv.2013.11.006","article-title":"Techniques for physicochemical characterization of nanomaterials","volume":"32","author":"Lin","year":"2014","journal-title":"Biotechnol. Adv"},{"key":"B48","author":"Linsinger","year":"2012","journal-title":"Requirements on Measurements for the Implementation of the European Commission Definition of the Term \u201cNanomaterial.\u201d"},{"key":"B49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/978-3-319-72041-8_8","article-title":"Relevance of physicochemical characterization of nanomaterials for understanding nano-cellular interactions","volume-title":"Cellular and Molecular Toxicology of Nanoparticles. Advances in Experimental Medicine and Biology","author":"Louro","year":"2018"},{"key":"B50","author":"L\u00f6vestam","year":"2010","journal-title":"Consideration on a Definition of Nanomaterial for Regulatory Purpose"},{"key":"B51","author":"Luther","year":"2004","journal-title":"Industrial Application of Nanomaterials\u2014Chances and Risks"},{"key":"B52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nnano.2013.48","article-title":"A tiered approach","volume":"8","author":"McCall","year":"2013","journal-title":"Nat. Nanotechnol"},{"key":"B53","article-title":"Chapter 61: Nanomedicine: small steps, big effects","volume-title":"CRC Concise Encyclopedia of Nanotechnology, 1st Edn.","author":"M\u00e9ndez-Rojas","year":"2009"},{"key":"B54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(24)01494-7","article-title":"Long-circulating and target-specific nanoparticles: theory to practice","volume":"53","author":"Moghimi","year":"2001","journal-title":"Pharmacol. Rev"},{"key":"B55","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/nnano.2012.207","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","volume":"7","author":"Monopoli","year":"2012","journal-title":"Nat. Nanotechnol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2018.06.024","article-title":"Regulatory challenges of nanomedicines and their follow-on versions: a generic or similar approach?","author":"M\u00fchlebach","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2217\/nnm.14.189","article-title":"Regulatory challenges and approaches to characterize nanomedicines and their follow-on similars","volume":"10","author":"M\u00fchlebach","year":"2015","journal-title":"Nanomedicine"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2011.01.007","article-title":"State of the art of nanocrystals-special features, production, nanotoxicology aspects and intracellular delivery","volume":"78","author":"M\u00fcller","year":"2011","journal-title":"Eur. J. Pharm. Biopharm"},{"key":"B59","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.1114397","article-title":"Toxic potential of materials at the nanolevel","volume":"311","author":"Nel","year":"2006","journal-title":"Science"},{"key":"B60","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nmat2442","article-title":"Understanding biophysicochemical interactions at the nano-bio interface","volume":"7","author":"Nel","year":"2009","journal-title":"Nat. Mater."},{"key":"B61","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2796.2009.02187.x","article-title":"Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology","volume":"267","author":"Oberd\u00f6rster","year":"2010","journal-title":"J. Intern. Med"},{"key":"B62","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1289\/ehp.7339","article-title":"Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles","volume":"113","author":"Oberd\u00f6rster","year":"2005","journal-title":"Environ. Health Perspect"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.proeng.2015.01.284","article-title":"Structure-activity relationship models for hazard assessment and risk management of engineered nanomaterials","volume":"102","author":"Oksel","year":"2015","journal-title":"Proc. Eng."},{"key":"B64","unstructured":"OssaD. Quality Aspects of Nano-Based Medicines SME Workshop: Focus on Quality for Medicines Containing Chemical Entities London2014"},{"key":"B65","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fchem.2014.00108","article-title":"Biomolecular corona on nanoparticles: a survey of recent literature and its implications in targeted drug delivery","volume":"2","author":"Pearson","year":"2014","journal-title":"Front. Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1039\/C3MH00106G","article-title":"Protein corona formation around nanoparticles\u2014from the past to the future","volume":"1","author":"Pino","year":"2014","journal-title":"Mater. Horiz."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1208\/s12248-016-9967-1","article-title":"Nanomedicines in the EU\u2014regulatory overview","volume":"18","author":"Pita","year":"2016","journal-title":"AAPS J"},{"key":"B68","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fphar.2011.00033","article-title":"In silico toxicology\u2014non-testing methods","volume":"2","author":"Raunio","year":"2011","journal-title":"Front. Pharmacol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1208\/s12249-010-9566-x","article-title":"Quality by design and process analytical technology for sterile products\u2013where are we now?","volume":"12","author":"Riley","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1289\/ehp.1001925","article-title":"Computational toxicology: realizing the promise of the toxicity testing in the 21st century","volume":"118","author":"Rusyn","year":"2010","journal-title":"Environ. Health Perspect"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/toxsci\/kfs095","article-title":"Predictive modeling of chemical hazard by integrating numerical descriptors of chemical structures and short-term toxicity assay data","volume":"127","author":"Rusyn","year":"2012","journal-title":"Toxicol. Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11051-018-4160-3","article-title":"Nanotoxicology and nanomedicine: making development decisions in an evolving governance environment","volume":"20","author":"Rycroft","year":"2018","journal-title":"J. Nanopart. Res."},{"key":"B73","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.bbrc.2015.08.023","article-title":"Regulatory aspects on nanomedicines","volume":"468","author":"Sainz","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B74","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/wnan.58","article-title":"Characterization of nanomaterials for toxicity assessment","volume":"1","author":"Sayes","year":"2009","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1208\/s12248-013-9533-z","article-title":"How to regulate nonbiological complex drugs (NBCD) and their follow-on versions: points to consider","volume":"16","author":"Schellekens","year":"2014","journal-title":"AAPS J"},{"key":"B76","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/nyas.12403","article-title":"Nanomedicines: addressing the scientific and regulatory gap","volume":"1313","author":"Tinkle","year":"2014","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B77","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijpharm.2009.05.006","article-title":"Quality by design approach to understand the process of nanosuspension preparation","volume":"377","author":"Verma","year":"2009","journal-title":"Int. J. Pharm."},{"key":"B78","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/toxsci\/kfm279","article-title":"How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization?","volume":"101","author":"Warheit","year":"2008","journal-title":"Toxicol. Sci"},{"key":"B79","first-page":"10","article-title":"Revisiting the definition of biocompatibility","volume":"14","author":"Williams","year":"2003","journal-title":"Med. Device Technol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.tox.2012.11.005","article-title":"Applying quantitative structure-activity relationship approaches to nanotoxicology: current status and future potential","volume":"313","author":"Winkler","year":"2013","journal-title":"Toxicology"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.addr.2012.08.005","article-title":"Interactions of nanomaterials and biological systems: implications to personalized nanomedicine","volume":"64","author":"Zhang","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B82","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nnano.2016.232","article-title":"Nano on reflection","volume":"11","author":"Zhao","year":"2016","journal-title":"Nat. Nanotechnol."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fchem.2018.00360\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T08:07:55Z","timestamp":1751789275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fchem.2018.00360\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":82,"alternative-id":["10.3389\/fchem.2018.00360"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2018.00360","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]},"article-number":"360"}}